Centre for Orthopaedic Research, Medical School, The University of Western Australia, Nedlands, WA, Australia.
New Technologies - Research Centre (NTC), University of West Bohemia, Univerzitní 8, 301 00 Pilsen, Czech Republic.
Acta Biomater. 2024 Aug;184:1-21. doi: 10.1016/j.actbio.2024.06.012. Epub 2024 Jun 13.
Surgical meshes play a significant role in the treatment of various medical conditions, such as hernias, pelvic floor issues, guided bone regeneration, and wound healing. To date, commercial surgical meshes are typically made of non-absorbable synthetic polymers, notably polypropylene and polytetrafluoroethylene, which are associated with postoperative complications, such as infections. Biological meshes, based on native tissues, have been employed to overcome such complications, though mechanical strength has been a main disadvantage. The right balance in mechanical and biological performances has been achieved by the advent of bioresorbable meshes. Despite improvements, recurrence of clinical complications associated with surgical meshes raises significant concerns regarding the technical adequacy of current materials and designs, pointing to a crucial need for further development. To this end, current research focuses on the design of meshes capable of biomimicking native tissue and facilitating the healing process without post-operative complications. Researchers are actively investigating advanced bioresorbable materials, both synthetic polymers and natural biopolymers, while also exploring the performance of therapeutic agents, surface modification methods and advanced manufacturing technologies such as 4D printing. This review seeks to evaluate emerging biomaterials and technologies for enhancing the performance and clinical applicability of the next-generation surgical meshes. STATEMENT OF SIGNIFICANCE: In the ever-transforming landscape of regenerative medicine, the embracing of engineered bioabsorbable surgical meshes stands as a key milestone in addressing persistent challenges and complications associated with existing treatments. The urgency to move beyond conventional non-absorbable meshes, fraught with post-surgery complications, emphasises the necessity of using advanced biomaterials for engineered tissue regeneration. This review critically examines the growing field of absorbable surgical meshes, considering their potential to transform clinical practice. By strategically combining mechanical strength with bioresorbable characteristics, these innovative meshes hold the promise of mitigating complications and improving patient outcomes across diverse medical applications. As we navigate the complexities of modern medicine, this exploration of engineered absorbable meshes emerges as a promising approach, offering an overall perspective on biomaterials, technologies, and strategies adopted to redefine the future of surgical meshes.
外科手术网片在治疗各种医疗病症中扮演着重要角色,如疝气、盆底问题、引导骨再生和伤口愈合等。迄今为止,商业用外科手术网片通常由不可吸收的合成聚合物制成,特别是聚丙烯和聚四氟乙烯,它们与术后并发症如感染有关。基于天然组织的生物网片已被用于克服这些并发症,但机械强度一直是主要的缺点。生物可吸收网片的出现实现了机械性能和生物性能的恰当平衡。尽管有所改进,但与外科手术网片相关的临床并发症的复发,对当前材料和设计的技术充分性提出了重大关注,这表明迫切需要进一步的发展。为此,当前的研究重点是设计能够仿生天然组织并促进愈合过程而无术后并发症的网片。研究人员正在积极研究先进的生物可吸收材料,包括合成聚合物和天然生物聚合物,同时还在探索治疗剂的性能、表面改性方法和先进制造技术,如 4D 打印。本综述旨在评估新兴生物材料和技术,以提高下一代外科手术网片的性能和临床适用性。
意义陈述:在不断变化的再生医学领域中,接受工程生物可吸收外科手术网片是解决与现有治疗方法相关的持续挑战和并发症的关键里程碑。超越传统不可吸收网片的紧迫性,这些网片存在术后并发症问题,强调了使用先进生物材料进行工程组织再生的必要性。本综述批判性地检查了可吸收外科手术网片这一日益增长的领域,考虑了它们在改变临床实践方面的潜力。通过策略性地结合机械强度和生物可吸收特性,这些创新的网片有望减轻各种医疗应用中的并发症并改善患者的预后。当我们应对现代医学的复杂性时,这种对工程可吸收网片的探索成为一种有前途的方法,提供了对生物材料、技术和策略的全面视角,这些策略被采用以重新定义外科手术网片的未来。
Acta Biomater. 2024-8
J Gynecol Obstet Biol Reprod (Paris). 2002-10
J Biomed Mater Res B Appl Biomater. 2020-4
Acta Biomater. 2025-3-15
ACS Appl Bio Mater. 2025-3-17
J Gynecol Obstet Biol Reprod (Paris). 2011-12
Surg Laparosc Endosc Percutan Tech. 2010-8
J Funct Biomater. 2025-7-29
Vet Med Sci. 2025-7
Biomimetics (Basel). 2025-2-12
Medicina (Kaunas). 2024-11-14
Adv Healthc Mater. 2024-12